These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 13386740)
1. [Diabetes mellitus, BZ 55, D 860, and glucagon]. RECKNAGEL K Medizinische; 1956 Nov; 1(46):1633-9. PubMed ID: 13386740 [No Abstract] [Full Text] [Related]
2. BZ 55 and D 860 in the treatment of diabetes mellitus. SCHNEIDER T; POLITZER WM S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061 [No Abstract] [Full Text] [Related]
3. [BZ-55, a peroral antidiabetic remedy with a possible glucagon-restraining effect]. ANDERSSON B Sven Lakartidn; 1956 Jan; 53(2):57-64. PubMed ID: 13311777 [No Abstract] [Full Text] [Related]
5. The value of BZ 55 in control of diabetes. MURRAY I; WANG I Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512 [No Abstract] [Full Text] [Related]
6. [BZ 55 of D 860 as oral antidiabetic]. MEHNERT B; MEHNERT H Munch Med Wochenschr; 1956 Sep; 98(39):1325-8. PubMed ID: 13378442 [No Abstract] [Full Text] [Related]
7. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)]. BERTRAM F Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958 [No Abstract] [Full Text] [Related]
8. Clinical trial of the new oral hypoglycaemic agent BZ 55. HUNT JA; OAKLEY W; LAWRENCE RD Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509 [No Abstract] [Full Text] [Related]
9. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
10. Tolbutamide in treatment of diabetes mellitus. BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469 [No Abstract] [Full Text] [Related]
11. The mechanism of action of the sulfonylureas in diabetes mellitus. LEVINE R; SOBEL GW Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633 [No Abstract] [Full Text] [Related]
12. CARBUTAMIDE and tolbutamide in diabetes. S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101 [No Abstract] [Full Text] [Related]
13. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
14. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related]
15. [Treatment for diabetes with sulfamide hypoglycemic agents]. DEUIL R Rev Prat; 1956 Dec; 6(33):3687-94. PubMed ID: 13408836 [No Abstract] [Full Text] [Related]
16. New orally effective adjuvants in the management of diabetes mellitus. O'DONOVAN CJ J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693 [No Abstract] [Full Text] [Related]
17. Tolbutamide in diabetes; some clinical and biochemical studies. CROWLEY MF; WOLFF FW; BLOOM A Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470 [No Abstract] [Full Text] [Related]
18. Sulfonylureas and diabetes mellitus. I. Clinical evaluation. COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475 [No Abstract] [Full Text] [Related]